Right ventricular dysfunction was associated with a significantly higher risk of all-cause mortality compared to normal right ventricular function in patients with left ventricular non-compaction cardiomyopathy (HR 5.132).
Cohort (n=117)
No
Does right ventricular dysfunction predict all-cause mortality in patients with left ventricular non-compaction cardiomyopathy?
Right ventricular dysfunction, assessed by comprehensive echocardiographic measurements, is an independent predictor of all-cause mortality in patients with left ventricular non-compaction cardiomyopathy.
Hazard Ratio: 5.132 (95% CI 2.003–13.15)
Absolute Event Rate: 26.4% vs 6.3%
p-value: p=0.0013
Background Various adverse outcomes such as mortality and rehospitalization are associated with left ventricular non-compaction (LVNC). Due to data limitations, prospective risk assessment for LVNC remains challenging. This study aimed to investigate the influence of right ventricular (RV) dysfunction on the clinical outcomes of patients with LVNC through accurate and comprehensive measurements of RV function. Methods and Results Overall, 117 patients with LVNC (47.6 ± 18.3 years, 34.2% male) were enrolled, including 53 (45.3%) and 64 (54.7%) patients with and without RV dysfunction, respectively. RV dysfunction was defined as meeting any two of the following criteria: (i) tricuspid annular systolic excursions 17 mm, (ii) tricuspid S′ velocity 10 cm/s, and (iii) RV fractional area change (FAC) 35%. The proportion of biventricular involvement was significantly higher in patients with RV dysfunction than in controls ( p = 0.0155). After a follow-up period of 69.0 33.5, 96.0 months, 18 (15.4%) patients reached the primary endpoint (all-cause mortality), with 14 (26.4%) and 4 (6.3%) from the RV dysfunction group and normal RV function group, respectively. The Kaplan–Meier method and log-rank test revealed that patients with RV dysfunction had a higher risk of all-cause mortality than those in the control group (hazard ratio HR: 5.132 2.003, 13.15, p = 0.0013). Similar results were obtained for patients with left ventricular ejection fraction (LVEF) 50% HR, 6.582; 95% confidence interval (CI), 2.045–21.19; p = 0.0367. The relationship between RV dysfunction and heart failure rehospitalization and implantation of implantable cardioverter-defibrillator (ICD)/cardiac resynchronization therapy (CRT) was not statistically significant (both p 0.05). The multivariable Cox proportional hazard modeling analysis showed that RV dysfunction (HR: 4.950 1.378, 17.783, p = 0.014) and impaired RV global longitudinal strain (RVGLS) (HR: 1.103 1.004, 1.212, p = 0.041) were independent predictors of mortality rather than increased RV end-diastolic area and decreased LVEF (both p 0.05). Conclusions RV dysfunction is associated with the prognosis of patients with LVNC.
Wang et al. (Mon,) conducted a cohort in Left ventricular non-compaction cardiomyopathy (LVNC) (n=117). Right ventricular dysfunction vs. Normal right ventricular function was evaluated on All-cause mortality (HR 5.132, 95% CI 2.003-13.15, p=0.0013). Right ventricular dysfunction was associated with a significantly higher risk of all-cause mortality compared to normal right ventricular function in patients with left ventricular non-compaction cardiomyopathy (HR 5.132).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: